Banner for Pharmacovigilance Oversight and Inspection Readiness Virtual Summit

Pharmacovigilance is responsible for the collection, assessment, identification, and communication of all drug safety information. In addition, PV focuses on the processing of safety information, adverse event reporting, and keeping up to date with guidelines and regulations.

The Pharmacovigilance Oversight and Inspection Readiness Virtual Summit will focus on how to achieve safety inspection readiness through effective partner collaboration and quality optimization strategies.

Interested in attending an in-person Pharmacovigilance event?

Learn more about our 2nd Pharmacovigilance Oversight Summit, taking place in Philadelphia, PA., here!



Top Reasons to PURCHASE

Reason one to attend
Analyze the importance of a Culture of Quality and its impact on safety
Reason two to attend
Learn tools to “survive” Inspections and Audits
Reason three to attend
Ensure streamline communication between partners, CROs and sponsors
Reason four to attend
Leverage learnings and challenges from PV audits to promote and ensure inspection readiness
Reason five to attend
Discuss new ICH guidelines and their effect on drug safety and pharmacovigilance
Reason six to attend
Recognize the value of PV systems to streamline communication and achieve inspection readiness
Reason seven to attend
Bridging the gap between PV innovation and PV quality – Level the play field for every drug safety stakeholder


This event is designed for pharmaceutical, biotech, and medical device professionals with responsibilities in the following areas:
  • Pharmacovigilance
  • Safety & Risk management
  • Drug safety
  • PV Compliance
  • Safety Surveillance
  • Medical Affairs
  • Regulatory Affairs
  • Inspection and Audit
  • Pharmacoepidemiology
  • Post-market studies
  • Medical product safety assessment
  • Drug Research & Development
  • Clinical Pharmacology
  • Medical information
  • Health outcomes